IGF-1 levels, which could track through life, have been associated with breast cancer risk, particularly premenopausal breast cancer risk (Renehan et al, 2004; Fletcher et al, 2005; Rinaldi et al, 2006). Here, IGF1 is linked to breast carcinoma.